CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 53 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,227 | -13.0% | 105 | 0.0% | 0.00% | – |
| Q2 2023 | $1,411 | -19.0% | 105 | 0.0% | 0.00% | – |
| Q1 2023 | $1,741 | -34.1% | 105 | -26.1% | 0.00% | – |
| Q4 2022 | $2,641 | +164.1% | 142 | +35.2% | 0.00% | – |
| Q3 2022 | $1,000 | – | 105 | +208.8% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 34 | -98.9% | 0.00% | -100.0% |
| Q2 2014 | $8,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 252,199 | $749,000 | 2.35% |
| MANGROVE PARTNERS IM, LLC | 3,031,965 | $9,005,000 | 1.14% |
| ARMISTICE CAPITAL, LLC | 10,000,000 | $29,700,000 | 1.08% |
| GABLES CAPITAL MANAGEMENT INC. | 432,864 | $1,286,000 | 0.83% |
| Worth Venture Partners, LLC | 268,682 | $798,000 | 0.66% |
| XTX MARKETS LLC | 18,749 | $56,000 | 0.27% |
| Capital Impact Advisors, LLC | 203,133 | $603,000 | 0.18% |
| Wealthspire Advisors, LLC | 337,770 | $1,003,000 | 0.06% |
| ROYCE & ASSOCIATES LP | 1,784,890 | $5,301,000 | 0.06% |
| XML Financial, LLC | 40,000 | $119,000 | 0.04% |